Literature DB >> 11376177

Fever in subarachnoid hemorrhage: relationship to vasospasm and outcome.

J Oliveira-Filho1, M A Ezzeddine, A Z Segal, F S Buonanno, Y Chang, C S Ogilvy, G Rordorf, L H Schwamm, W J Koroshetz, C T McDonald.   

Abstract

OBJECTIVE: To investigate the causes of fever in subarachnoid hemorrhage (SAH) and examine its relationship to outcome.
BACKGROUND: Fever adversely affects outcome in stroke. Patients with SAH are at risk for cerebral ischemia due to vasospasm (VSP). In these patients, fever may be both caused by, and potentiate, VSP-mediated brain injury.
METHODS: The authors prospectively studied patients admitted to a neurologic intensive care unit with nontraumatic SAH, documenting Hunt-Hess grade, Fisher group, Glasgow Coma Score, bacterial culture data, daily transcranial Doppler mean velocities, and maximum daily temperatures. Patients were classified as febrile (temperature above 38.3 degrees C for at least 2 consecutive days) or afebrile (no fever or isolated episodes of temperature above 38.3 degrees C). VSP was verified by either transcranial Doppler or angiographic criteria. Rankin scale scores on discharge were dichotomized into good (0 to 2) or poor (3 to 6) outcomes.
RESULTS: Ninety-two consecutive patients were studied. Thirty-eight patients were classified as febrile. No source for infection was found in 10 of 38 (26%) patients. In a multivariate analysis, three variables independently predicted fever occurrence: ventriculostomy (OR, 8.5 [CI, 2.4 to 29.7]), symptomatic VSP (OR, 5.0 [CI, 1.03 to 24.5]), and older age (OR, 1.75 per 10 years [CI, 1.02 to 3.0]). Poor outcome was related to fever (OR, 1.4 per each day febrile [CI, 1.1 to 1.88]), older age (OR, 1.64 per 10 years [CI, 1.04 to 2.58]), and intubation (OR, 21.8 [CI, 5.6 to 84.5]).
CONCLUSION: Fever in SAH is associated with vasospasm and poor outcome independently of hemorrhage severity or presence of infection.

Entities:  

Mesh:

Year:  2001        PMID: 11376177     DOI: 10.1212/wnl.56.10.1299

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  58 in total

1.  Intravascular cooling for fever control.

Authors:  Stephan A Mayer
Journal:  Curr Neurol Neurosci Rep       Date:  2003-11       Impact factor: 5.081

Review 2.  Therapeutic hypothermia for acute neurological injuries.

Authors:  Lucia Rivera-Lara; Jiaying Zhang; Susanne Muehlschlegel
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

3.  Intensive care unit management of aneurysmal subarachnoid hemorrhage.

Authors:  Jennifer E Fugate; Alejandro A Rabinstein
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

4.  Treatment of resistant fever: new method of local cerebral cooling.

Authors:  Susanne Mink; Urs Schwarz; Regina Mudra; Christoph Gugl; Jürg Fröhlich; Emanuela Keller
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

Review 5.  Extracerebral organ dysfunction in the acute stage after aneurysmal subarachnoid hemorrhage.

Authors:  Wouter J Schuiling; Paul J W Dennesen; Gabriël J E Rinkel
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

6.  Rise of the machines: controlling the body temperature of critically ill patients by endovascular catheters.

Authors:  Stefan Schwab; Rainer Kollmar
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 7.  Therapeutic temperature modulation in neurocritical care.

Authors:  Neeraj Badjatia
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

Review 8.  Fever management in SAH.

Authors:  V Scaravilli; G Tinchero; G Citerio
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

Review 9.  Controversies in the temperature management of critically ill patients.

Authors:  Yasufumi Nakajima
Journal:  J Anesth       Date:  2016-06-28       Impact factor: 2.078

10.  A prospective, observational clinical trial of fever reduction to reduce systemic oxygen consumption in the setting of acute brain injury.

Authors:  J Steven Hata; Constance R Shelsky; Bradley J Hindman; Thomas C Smith; Jonathan S Simmons; Michael M Todd
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.